Oruka Therapeutics, Inc. Common Stock Shares Outstanding

• Oruka Therapeutics, Inc. showed an increase of +30.1% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Oruka Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
• XBRL data for this metric is available from 2010 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2010 to 2025), Oruka Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 451.5%.
• Historical annual values: Fiscal year 2025: 48.72 million shares | Fiscal year 2024: 37.44 million shares | Fiscal year 2024: 3.20 million shares | Fiscal year 2023: 14.50 million shares | Fiscal year 2022: 14.41 million shares | Fiscal year 2021: 14.41 million shares | Fiscal year 2020: 9.55 million shares | Fiscal year 2019: 1.59 million shares | Fiscal year 2018: 773,558 shares | Fiscal year 2017: 11.78 million shares | Fiscal year 2016: 9.08 million shares | Fiscal year 2015: 9.05 million shares | Fiscal year 2014: 3.02 million shares | Fiscal year 2013: 15.69 million shares | Fiscal year 2012: 2.66 million shares | Fiscal year 2011: 2.03 million shares | Fiscal year 2010: 8.83 million shares.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026